ResearcherBaşkent UniversityActive in the last 2 years
Erkan Topkan
Matched on ORCID iD 0000-0001-8120-7123; OpenAlex author ID A5064628495.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 6 (first author 2, last author 2)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Labs led
- 1
- Collaborators
- 6
2012: 2 papers · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 6
- High Systemic Immune-Inflammation Index Values Before Treatment Predict Poor Pancreatic Cancer Outcomes After Definitive Chemoradiotherapy. First author DOI 10.1177/11795549241298552↗
- High Measures of Pre-Chemoradiotherapy Platelet-to-Albumin Ratio Indicates Poor Prognosis in Locally Advanced Pancreatic Cancer Patients. Co-author DOI 10.2147/tcrm.s359553↗
- Impact of presence and degree of pretreatment weight loss in locally-advanced pancreatic cancer patients treated with definitive concurrent chemoradiotherapy. Last author DOI 10.1016/j.pan.2016.03.006↗
- In regard to Bjerregaard et al. Re: Prognostic factors for survival and resection in patients with initial nonresectable locally advanced pancreatic cancer tre… Last author DOI 10.1016/j.ijrobp.2012.03.016↗
- Impact of omission of elective nodal irradiation on treatment outcomes in locally advanced pancreatic adenocarcinoma patients treated with definitive concurren… First author DOI 10.1016/j.pan.2012.08.006↗
- Prognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with locally advanced pancreatic cancer treat… Co-author DOI 10.1186/1748-717x-7-37↗
Closest collaborators
The 6 strongest of 6 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Uğur Selek · 3 shared papers, 2012–2024
- Paper High Systemic Immune-Inflammation Index Values Before Treatment Predict Poor Pancreatic Cancer Outcomes After Definitiv… DOI 10.1177/11795549241298552↗
- Paper High Measures of Pre-Chemoradiotherapy Platelet-to-Albumin Ratio Indicates Poor Prognosis in Locally Advanced Pancreati… DOI 10.2147/tcrm.s359553↗
- Paper Prognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with … DOI 10.1186/1748-717x-7-37↗
- Berrin Pehlivan · 2 shared papers, 2022–2024
- Paper High Systemic Immune-Inflammation Index Values Before Treatment Predict Poor Pancreatic Cancer Outcomes After Definitiv… DOI 10.1177/11795549241298552↗
- Paper High Measures of Pre-Chemoradiotherapy Platelet-to-Albumin Ratio Indicates Poor Prognosis in Locally Advanced Pancreati… DOI 10.2147/tcrm.s359553↗
- Ahmet Küçük · 2 shared papers, 2022–2024
- Paper High Systemic Immune-Inflammation Index Values Before Treatment Predict Poor Pancreatic Cancer Outcomes After Definitiv… DOI 10.1177/11795549241298552↗
- Paper High Measures of Pre-Chemoradiotherapy Platelet-to-Albumin Ratio Indicates Poor Prognosis in Locally Advanced Pancreati… DOI 10.2147/tcrm.s359553↗
- Cem Parlak · 3 shared papers, 2012–2013
- Paper In regard to Bjerregaard et al. Re: Prognostic factors for survival and resection in patients with initial nonresectabl… DOI 10.1016/j.ijrobp.2012.03.016↗
- Paper Impact of omission of elective nodal irradiation on treatment outcomes in locally advanced pancreatic adenocarcinoma pa… DOI 10.1016/j.pan.2012.08.006↗
- Paper Prognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with … DOI 10.1186/1748-717x-7-37↗
- Berna Akkuş Yıldırım · 1 shared paper, 2016
- Fuat Yapar · 1 shared paper, 2012
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.